Mind Medicine (MindMed) Inc. held its 2025 Annual General and Special Meeting of Shareholders on June 12, 2025. During the meeting, shareholders approved the adoption of the 2025 Equity Incentive Plan, elected six nominees to the Board of Directors, and approved the appointment of KPMG LLP as the independent auditor until the next annual meeting.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.